Plains GP Holdings LP Class A Aktie News

Israel has attacked Iran to prevent it from getting a nuclear weapon. This has caused markets to experience considerable turmoil. I share 2 big dividend stocks set to soar in response.

It is rare to buy an investment that is both deeply discounted and enjoying strong momentum. However, we share two such opportunities right now. We share why we think they are still undervalued and have significantly further to run.

High-yield stocks with strong balance sheets and growth profiles are rare. I share two of these opportunities here. Both of these opportunities issue 1099 tax forms.

It is rare to find 9%+ yielding dividend growth stocks that would qualify as blue chips. However, today, Mr. Market is offering several of them. We share two that are attractive buys on the dip.

Plains GP Holdings, L.P. (NASDAQ:PAGP ) Q1 2025 Earnings Conference Call May 9, 2025 10:00 AM ET Company Participants Blake Fernandez - VP, IR Willie Chiang - Chairman and CEO Al Swanson - EVP and CFO Harry Pefanis - President and Co-Founder Chris Chandler - EVP and COO Jeremy Goebel - EVP and CCO Conference Call Participants Gabriel Moreen - Mizuho Manav Gupta - UBS Michael Blum - Wells Fargo ...

I love high-yield blue-chip stocks, as they fit in very well with my opportunistic capital recycling strategy. Want a potentially safe double-digit income? These stocks deliver — one does not. One of these stocks yields nearly 10% and just hiked its payout by 20%.

The 'Undercovered' Dozen highlights 12 lesser-covered stocks, offering investment opportunities and fostering community discussion on their potential. Abeona Therapeutics is seen as a Buy due to promising FDA approvals for pz-cel and UX111, potentially transforming the company with its first commercial products by 2025. Plains GP Holdings offers stable cash flows and high dividends in the volat...

Plains GP Holdings offers exposure to Plains All American with a simpler tax structure, boasting a vast network of pipelines and storage facilities. Despite market volatility, PAGP's fee-based midstream operations ensure stable cash flows, with strong FCF and a growing dividend yield of 7.04%. The company's valuation metrics are attractive, with a P/CF of 1.51 and a P/E of 12.18, highlighting i...